Drugs Made in America AcquisDMAA
13F holders, Q1 2025 (March 31)24holders
$8.70avg. 13F price*
At the end of Q1 2025, 24 institutions reported holding Drugs Made in America Acquis (DMAA) in their 13F filings. The largest holders were Karpus Management, Inc. ($23.3M), First Trust Capital Management L.P. ($20.7M) and Polar Asset Management Partners Inc. ($19.0M).
- Company
- Drugs Made in America Acquis
- CUSIP
- G2847J104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 24 | $171.3M |
| Exits | 0 | $0 |
Ownership 24 holders
| Karpus Management, Inc. | 0.75% | New | 2,324,034 | $23.3M |
| First Trust Capital Management L.P. | 1.50% | New | 2,066,702 | $20.7M |
| Polar Asset Management Partners Inc. | 0.88% | New | 1,900,000 | $19.0M |
| Glazer Capital, LLC | 0.93% | New | 1,822,952 | $18.3M |
| Hudson Bay Capital Management LP | 0.13% | New | 1,800,000 | $18.0M |
| Westchester Capital Management, LLC | 0.58% | New | 979,000 | $9.8M |
| Aristeia Capital, L.L.C. | 0.58% | New | 900,000 | $9.0M |
| Quarry LP | 1.71% | New | 650,000 | $6.5M |
| Wolverine Asset Management LLC | 0.45% | New | 603,038 | $6.0M |
| Atw Spac Management LLC | 9.97% | New | 570,000 | $5.7M |
| Mizuho Securities USA LLC | 0.12% | New | 542,962 | $5.4M |
| LMR Partners LLP | 0.14% | New | 500,000 | $5.0M |
| Whitebox Advisors LLC | 0.34% | New | 400,000 | $4.0M |
| AQR Arbitrage LLC | 0.17% | New | 380,314 | $3.8M |
| DLD Asset Management, LP | 3.03% | New | 350,000 | $3.5M |
| Mangrove Partners Im, LLC | 0.40% | New | 350,000 | $3.5M |
| Toronto Dominion Bank | 0.01% | New | 2,210,100 | $3.5M |
| Schonfeld Strategic Advisors LLC | 0.01% | New | 200,000 | $2.0M |
| Crossingbridge Advisors, LLC | 1.16% | New | 850,000 | $1.3M |
| Goldman Sachs Group Inc. | 0.00% | New | 119,686 | $1.2M |
| Warberg Asset Management LLC | 3.92% | New | 92,055 | $922K |
| Geode Capital Management, LLC | 0.00% | New | 45,462 | $456K |
| Virtu Financial LLC | 0.02% | New | 31,777 | $318K |
| Morgan Stanley | 0.00% | New | 20 | $200 |
"% of holder's portfolio" is DMAA's weight in each manager's 13F, not the share of Drugs Made in America Acquis the manager owns.